What dekapenta labs does

Dekapenta Labs S.L. is a Barcelona-based Contract Research Organization (CRO) founded in May 2022 that delivers physicochemical analysis services to pharmaceutical, biotechnology, food, and cosmetics companies. The company operates a 50 m2 laboratory within the Parc Cientific de Barcelona, equipped with gas and liquid chromatography systems (GC/HPLC/UPLC), a triple quadrupole mass spectrometer coupled to UPLC (UPLC-MS/MS), titrators, Karl Fischer moisture analyzers, and precision balances. Its service portfolio is organized around three pillars: Quality Control (batch release and physicochemical testing), ICH-compliant Stability Studies, and Development Studies covering analytical method development, validation, transfer, and nitrosamine/genotoxic impurity analysis at parts-per-billion sensitivity.

The company monetizes via project-based professional services engagements with quote-based pricing tailored to individual client requirements. Go-to-market is direct and sales-led, with prospective clients engaging via website inquiry forms that capture analytical needs, scope, and timelines; the company does not appear to use intermediaries or digital marketplaces. Customers span four primary verticals — pharmaceutical, biotechnology, food, and cosmetics — with pharmaceutical treated as the lead vertical given the company's pursuit of EU GMP certification. The business is bootstrapped with no disclosed external funding rounds, founders' capital having funded the December 2022 acquisition of a UPLC-MS/MS system and the operational build-out culminating in AEMPS-issued EU GMP certification in April 2023. Operating geography is currently regional (Spain/Western Europe), with a multilingual website (English, Spanish, Catalan) suggesting latent cross-border engagement intent.

Name

dekapenta labs

Legal name

DEKAPENTA LABS S.L.

Website

https://dekapenta.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

1–10 employees

Short description

Dekapenta Labs is a Barcelona-based CRO founded in 2022 providing GMP-certified physicochemical analysis services to pharmaceutical, biotech, food, and cosmetics companies. It operates a 50 m2 laboratory offering quality control, ICH stability studies, method development, and nitrosamine testing.

Ownership category

akta.pro rank

NAICS

Testing Laboratories and Services (54138)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)

akta.pro primary industry

Toxicology & Safety Assessment CROs (GLP) (HLAGAAAC)

Keywords

• Physicochemical analysis services
• Contract research organization
• GMP quality control
• Analytical method development
• ICH stability studies

Headquarters

HQ city

Barcelona

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Contract Research Organization (CRO) Analytical Services: Dekapenta Labs generates revenue by providing physicochemical analysis services on a contract basis to pharmaceutical, biotech, food, and cosmetics companies. Services include quality control (QC) testing, ICH stability studies, analytical method development, validations, transfers, and specialized nitrosamine/genotoxic impurity testing. The business model is project-based professional services where clients engage the laboratory for specific analytical needs, enabling their focus on core business activities.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Dekapenta Labs is a Contract Research Organization (CRO) that performs physicochemical analysis services for third parties. It delivers three integrated service lines from a GMP-certified laboratory in Barcelona: Quality Control (batch release and sample testing), ICH Stability Studies (protocols, photostability, thermal cycle, ongoing stability, trend analysis), and Development Studies (analytical method development, stress testing, validation, transfer, and nitrosamine/genotoxic impurity analysis using UPLC-MS/MS). Services target pharmaceutical, biotech, food, and cosmetics companies that need to outsource analytical testing and regulatory-compliant quality control work.

Product overview

Dekapenta Labs is a Contract Research Organization (CRO) providing physicochemical analysis services to the pharmaceutical, biotech, food, and cosmetics industries. The company operates as a single integrated service offering organized around three interconnected service lines: Quality Control (QC) for batch release and sample analysis, Stability Studies following ICH guidelines for product shelf-life determination, and Development Studies encompassing analytical method development, validation, transfers, and specialized nitrosamine/genotoxic impurity testing. The services are delivered through a GMP-certified laboratory equipped with chromatography equipment (GC/HPLC/UPLC), mass spectrometry (UPLC-MS/MS), titrators, Karl Fischer (KF) titrators, and precision balances.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• Detection capability at ppb (parts per billion) levels for nitrosamines and genotoxic impurities

Segments4 records

Ideal customer profiles3 records

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Customer concentration

• LinkedInlinkedin.com/company/dekapenta-labs

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about dekapenta labs